STXBP1 and SYNGAP1 natural history study
Part of Genetic & congenital clinical trials.
This study follows people with STXBP1 or SYNGAP1 gene changes over time to learn more about how these conditions affect the body and mind. It does not test a treatment but helps researchers understand the natural course of the disorder.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) have a confirmed change in the STXBP1 or SYNGAP1 gene that causes the disorder.
- You can be any age, male or female.
- You cannot have a major brain injury, stroke, or serious heart problem from birth.
- You cannot have a mutation in another gene that clearly causes a different brain disorder.
- If you are a female of childbearing age, you must not be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people with a confirmed STXBP1 genetic change to help prepare for future clinical trials. It collects information about the condition to better understand it.
This study is looking at children with STXBP1-related encephalopathy to better understand the condition and find biological markers (clues in the body) that can help with diagnosis and treatment. It involves detailed medical and cognitive assessments to learn more about how the condition affects each child.
This early-phase study tests how safe ETX101 is and whether it can help reduce seizures in young children with Dravet syndrome caused by an SCN1A gene change. It mainly enrolls infants and children with a specific type of seizure history and genetic result.
This study follows children with Dravet syndrome caused by a specific SCN1A gene change to understand how the condition develops over time. It may help families know more about what to expect.
This trial studies a one-time gene therapy meant to help children with SPG50 disease caused by changes in the AP4M1 gene. Researchers will give the treatment and closely monitor safety and early signs of benefit.
This study looks at how people with FOXP1-related neurodevelopmental conditions work and how they’re affected, using genetic, medical, and thinking/learning tests. It may help researchers better understand the condition and improve future care.
Hear when a new Genetic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.